Why I Expect The Biotech Sell-Off To Continue Into 2015
Sammy Pollack - at Seeking Alpha - Wed Dec 24, 7:08AM CST
BIIB: 340.89 (+5.13), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), IBB: 299.80 (+5.12), AMGN: 160.67 (+3.15), REGN: 400.12 (+6.07), CELG: 109.60 (+3.48)
Regeneron's Valuation Has Moved Ahead Of Its Growth Potential
Stock Market Sherpa - at Seeking Alpha - Wed Dec 24, 6:27AM CST
REGN: 400.12 (+6.07)
Watch for Regeneron Pharmaceuticals to Potentially Rebound After Falling 4.58% Yesterday
Comtex SmarTrend(R) - Tue Dec 23, 3:44PM CST
Regeneron Pharmaceuticals (NASDAQ:REGN) traded in a range yesterday that spanned from a low of $383.87 to a high of $410.96. Yesterday, the shares fell 4.6%, which took the trading range below the 3-day low of $410.15 on volume of 2.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
REGN: 400.12 (+6.07)
Dow Reaches Record Close as Santa Claus Rally Hits Day 5
at The Street - Tue Dec 23, 3:04PM CST
The Dow Jones Industrial Average breaks through 18,000 on Tuesday as third-quarter GDP shows signs of better-than-expected economic health.
PSX: 72.10 (-0.46), HTZ: 24.38 (-0.09), GMCR: 137.65 (+1.10), OCN: 14.88 (-0.14), XOM: 93.78 (-0.81), NQ: 4.32 (-0.36), XLV: 68.64 (+0.50), AGO: 26.28 (+0.23), ESRX: 85.48 (-0.40), RDN: 16.78 (+0.18), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), ABBV: 66.21 (+1.86), CVX: 113.47 (-0.48), SWN: 28.46 (-0.46), WAG: 76.67 (+0.16), REGN: 400.12 (+6.07), XLE: 80.13 (-0.59)
Fresh Milestones For Dow, S&P 500 But Biotechs Hit
at Investor's Business Daily - Tue Dec 23, 1:48PM CST
The Dow Jones industrial average and S&P 500 notched fresh all-time highs Tuesday, but the Nasdaq lagged as biotech stocks sold off hard. The Dow added 0.6%, with about one-third of its components up 1% or more. The S&P 500 rose 0.4% and the Nasdaq...
BIIB: 340.89 (+5.13), VRX: 140.33 (-0.22), CDW: 35.75 (+0.14), CELG: 109.60 (+3.48), NOAH: 20.44 (-1.00), BIDU: 230.98 (-2.18), CALM: 42.45 (-1.73), ABG: 77.12 (+0.43), FLT: 149.17 (-0.93), REGN: 400.12 (+6.07)
Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations
at The Street - Tue Dec 23, 1:25PM CST
The Dow Jones Industrial Average breaks through 18,000 on Tuesday as third-quarter GDP shows signs of better-than-expected economic health.
GPRO: 66.41 (+4.87), GMCR: 137.65 (+1.10), OCN: 14.88 (-0.14), NQ: 4.32 (-0.36), XLV: 68.64 (+0.50), AGO: 26.28 (+0.23), ESRX: 85.48 (-0.40), RDN: 16.78 (+0.18), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), ABBV: 66.21 (+1.86), SWN: 28.46 (-0.46), WAG: 76.67 (+0.16), REGN: 400.12 (+6.07)
Dow Crosses 18,000 But Medical-Related Groups Fall Hard
at Investor's Business Daily - Tue Dec 23, 12:22PM CST
The Dow Jones industrial average and S&P 500 notched fresh all-time highs Tuesday, cheered by a robust upward revision to Q3 gross domestic product. The Dow was in the driver's seat in early afternoon trading, but the Nasdaq had a hard time keeping...
DD: 74.79 (-0.40), BA: 131.24 (+1.21), EPAM: 48.84 (+0.33), CDW: 35.75 (+0.14), REGN: 400.12 (+6.07), CELG: 109.60 (+3.48)
Dow Industrials Top 18,000 but Biopharma Stocks Drag Nasdaq Lower
at The Street - Tue Dec 23, 10:29AM CST
The Dow Jones Industrial Average breaks through 18,000 on Tuesday as stock markets gain.
AVP: 9.22 (-0.07), GMCR: 137.65 (+1.10), NQ: 4.32 (-0.36), SBUX: 81.27 (-0.16), AGO: 26.28 (+0.23), ESRX: 85.48 (-0.40), RDN: 16.78 (+0.18), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), ABBV: 66.21 (+1.86), SWN: 28.46 (-0.46), WAG: 76.67 (+0.16), REGN: 400.12 (+6.07)
Jim Cramer Answers Twitter (TWTR) Questions on Gilead, WhiteWave Foods, and More
at The Street - Mon Dec 22, 12:37PM CST
TheStreet's Jim Cramer answers Twitter (TWTR) questions from the floor of the New York Stock Exchange.
WWAV: 35.98 (+0.72), BIIB: 340.89 (+5.13), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), VALE: 8.09 (-0.05), KRFT: 63.90 (-0.11), ABBV: 66.21 (+1.86), DF: 18.96 (-0.01), TWTR: 37.61 (+0.04), PANW: 125.99 (+0.77), REGN: 400.12 (+6.07), K: 67.02 (-0.22), CELG: 109.60 (+3.48)
Stocks Struggle To Hold Gains; Alaska Air, Spirit Up
at Investor's Business Daily - Mon Dec 22, 9:34AM CST
Stocks got off to a mixed start, but quickly turned positive in the shortened holiday week, with drugmakers showing particular weakness at Monday's open. The Dow Jones industrial average led, up 0.4%. The Nasdaq backed out of early losses to a 0.2%...
BIIB: 340.89 (+5.13), ESRX: 85.48 (-0.40), SAVE: 75.68 (+1.52), GILD: 91.29 (+1.84), MRK: 57.46 (+0.25), AMGN: 160.67 (+3.15), ABBV: 66.21 (+1.86), ALK: 58.72 (+1.97), REGN: 400.12 (+6.07), CELG: 109.60 (+3.48)
The Market's 10 Best Stocks
Dan Caplinger, The Motley Fool - Motley Fool - Sun Dec 21, 7:02AM CST
Source: Wikimedia Commons. Investors are always searching for the best possible stocks. That's because if you can identify a winning stock before it takes off, it can have a life-changing impact on your finances. In order to find those stocks,...
NFLX: 342.10 (+5.67), NEU: 405.00 (+5.94), MNST: 112.56 (+0.52), OPK: 9.63 (+0.21), GMCR: 137.65 (+1.10), ALXN: 181.96 (+3.09), ILMN: 186.22 (+2.72), AAPL: 112.01 (-0.53), REGN: 400.12 (+6.07), PCLN: 1,149.78 (+2.17)
Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Dec 19, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. What should the Seeking Alpha community be reading and writing about? Please leave...
SPHS: 0.46 (+0.02), ASPX: 49.93 (-0.10), MDVN: 99.23 (+1.23), CYCC: 0.69 (+0.01), OPK: 9.63 (+0.21), NLNK: 39.08 (+1.36), JUNO: 39.99 (+2.71), REGN: 400.12 (+6.07), MYGN: 36.50 (+0.28), PFE: 31.42 (-0.03), IMGN: 5.90 (+0.13), AMGN: 160.67 (+3.15), GSK: 42.85 (+0.11), BMY: 59.15 (-0.01), BLRX: 1.68 (-0.01), OREX: 5.98 (+0.01), DVA: 76.06 (+0.07), BLCM: 19.30 (+0.18), CBST: 100.29 (-0.09), GILD: 91.29 (+1.84), GERN: 3.06 (+0.05), MRK: 57.46 (+0.25), NVS: 93.91 (+0.66)
Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half
at The Street - Fri Dec 19, 9:46AM CST
TheStreet's Jim Cramer takes a look at Celgene's positive news, as well as the bad news that caused shares of ImmunoGen to be nearly cut in half.
BIIB: 340.89 (+5.13), ISIS: 59.49 (+1.88), GILD: 91.29 (+1.84), IMGN: 5.90 (+0.13), REGN: 400.12 (+6.07), CELG: 109.60 (+3.48)
Regeneron Announces Presentation and Panel Discussion at the 33rd Annual J.P. Morgan Healthcare Conference
PR Newswire - Fri Dec 19, 8:30AM CST
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the 33rd Annual J.P. Morgan Healthcare Conference as follows:
JPM: 62.48 (unch), REGN: 400.12 (+6.07)
The Best Healthcare Stocks of 2014: Which Is Our Favorite for 2015?
Todd Campbell, The Motley Fool - Motley Fool - Fri Dec 19, 6:44AM CST
From Medicaid expansion to cancer drugs to minimally invasive treatment for heart disease, Industry Focus looks at the 10 top performers among large-cap healthcare stocks in 2014. There were some surprises on the list this year, with strong showings...
AGN: 210.12 (+0.95), MDVN: 99.23 (+1.23), CNC: 105.96 (+1.03), JNJ: 104.59 (+0.31), VRX: 140.33 (-0.22), ACT: 254.20 (-1.68), EW: 130.75 (+1.17), SNY: 46.35 (+0.50), REGN: 400.12 (+6.07)
Hypercholesterolemia - Pipeline Review, H2 2014
M2 - Fri Dec 19, 5:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/5snkwx/hypercholesterolem) has announced the addition of the "Hypercholesterolemia - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Hypercholesterolemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hypercholesterolemia and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Hypercholesterolemia - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Hypercholesterolemia pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Companies Mentioned: - Bristol-Myers Squibb Company - Johnson & Johnson - Amgen - Eli Lilly and Company - Merck & Co - Pfizer - Santaris Pharma - SoluBest - Alnylam Pharmaceuticals - Regeneron Pharmaceuticals - CrystalGenomics - Catabasis Pharmaceuticals - Planet Biotechnology - Zhejiang Hisun Pharmaceutical - Esperion Therapeutics - Progenra - Serometrix - Hanmi Pharmaceuticals - AtheroNova. - Immune Response BioPharma - Agilvax - Michigan Life Therapeutics - LondonPharma - Dybly For more information visit http://www.researchandmarkets.com/research/5s...lesterolem
JNJ: 104.59 (+0.31), ESPR: 35.97 (-0.08), MRK: 57.46 (+0.25), AMGN: 160.67 (+3.15), LLY: 70.16 (+0.42), BMY: 59.15 (-0.01), REGN: 400.12 (+6.07)
Cramer's Mad Money - Which Biotech Is The Next Regeneron? (12/18/14)
SA Editor Miriam Metzinger - Seeking Alpha - Fri Dec 19, 4:45AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday December 18. Recipe For a Rally: Rite Aid (NYSE: RAD ), Kraft (NASDAQ: KRFT ), Accenture (NYSE: ACN ), Darden (NYSE: DRI ), Boeing (NYSE: BA ), 3M (NYSE:...
MMM: 166.96 (+0.09), ISIS: 59.49 (+1.88), Q: 59.48 (+0.01), JBL: 21.88 (+0.17), WYNN: 150.90 (-0.79), KRFT: 63.90 (-0.11), MGM: 20.77 (-0.17), BA: 131.24 (+1.21), ACN: 91.32 (-0.10), REGN: 400.12 (+6.07), DRI: 58.42 (-0.09), RAD: 7.26 (-0.09)
Jim Cramer's 'Mad Money' Recap: 10 Reasons We'll Have a Santa Claus Rally
at The Street - Thu Dec 18, 7:10PM CST
Cramer lists 10 ingredients in this seasonally strong market that will lead to a rally.
WFM: 48.67 (-0.40), MMM: 166.96 (+0.09), WMT: 86.43 (-0.23), HSBC: 47.71 (+0.18), M: 64.26 (+0.22), BA: 131.24 (+1.21), CELG: 109.60 (+3.48), SBUX: 81.27 (-0.16), RIG: 18.77 (-0.37), ISIS: 59.49 (+1.88), JPM: 62.48 (unch), Q: 59.48 (+0.01), GILD: 91.29 (+1.84), KBR: 17.00 (-0.13), FLR: 60.30 (-0.26), COST: 143.65 (-0.50), REGN: 400.12 (+6.07)
'Mad Money' Lightning Round: GE Is a Good Stock With Good Yield
at The Street - Thu Dec 18, 5:00AM CST
Cramer is skittish on Sanofi, can't recommend C&J Energy Services and doesn't want you in Annaly Capital.
NLY: 11.21 (-0.05), GE: 25.83 (-0.05), CJES: 13.39 (-0.29), BCRX: 11.83 (+0.76), DDD: 30.54 (-0.64), AGIO: 109.67 (+2.45), ABBV: 66.21 (+1.86), BMY: 59.15 (-0.01), SNY: 46.35 (+0.50), HPQ: 40.54 (+0.18), REGN: 400.12 (+6.07), CELG: 109.60 (+3.48)
Jim Cramer's 'Mad Money' Recap: Why This Market Is All About Velocity
at The Street - Wed Dec 17, 7:16PM CST
A day's rest from the selling in oil will allow investors, analysts and oil companies themselves some time to assess their situations, Cramer says.
MNST: 112.56 (+0.52), BCRX: 11.83 (+0.76), CJES: 13.39 (-0.29), GE: 25.83 (-0.05), CLX: 105.46 (-0.62), DDD: 30.54 (-0.64), KMB: 117.77 (-0.21), RRD: 16.84 (+0.07), BMY: 59.15 (-0.01), KS: 29.97 (+0.03), HPQ: 40.54 (+0.18), CELG: 109.60 (+3.48), HAIN: 117.25 (+0.23), NLY: 11.21 (-0.05), CVS: 97.89 (+0.02), ABBV: 66.21 (+1.86), AGIO: 109.67 (+2.45), SNY: 46.35 (+0.50), REGN: 400.12 (+6.07)